Literature DB >> 10784507

Inflammation-mediated rheumatic diseases and atherosclerosis.

S Manzi1, M C Wasko.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10784507      PMCID： PMC1753135          DOI： 10.1136/ard.59.5.321

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  60 in total

Review 1.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

2.  Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL.

Authors:  R Wu; Y H Huang; L S Elinder; J Frostegård
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-04       Impact factor: 8.311

Review 3.  Biologic agents for treating rheumatoid arthritis. Concepts and progress.

Authors:  L W Moreland; L W Heck; W J Koopman
Journal:  Arthritis Rheum       Date:  1997-03

4.  Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction.

Authors:  R Wu; S Nityanand; L Berglund; H Lithell; G Holm; A K Lefvert
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

5.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.

Authors:  S J Hwang; C M Ballantyne; A R Sharrett; L C Smith; C E Davis; A M Gotto; E Boerwinkle
Journal:  Circulation       Date:  1997-12-16       Impact factor: 29.690

6.  Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.

Authors:  S L Morgan; J E Baggott; J Y Lee; G S Alarcón
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

7.  Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall.

Authors:  L S Elinder; A Dumitrescu; P Larsson; U Hedin; J Frostegård; H E Claesson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

8.  Abnormal homocysteine metabolism in rheumatoid arthritis.

Authors:  R Roubenoff; P Dellaripa; M R Nadeau; L W Abad; B A Muldoon; J Selhub; I H Rosenberg
Journal:  Arthritis Rheum       Date:  1997-04

9.  Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies?

Authors:  F Galtier-Dereure; C Biron; M Vies; V Bourgeois; J F Schved; J Bringer
Journal:  Lupus       Date:  1998       Impact factor: 2.911

10.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling.

Authors:  F Mach; U Schönbeck; G K Sukhova; E Atkinson; P Libby
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962
View more
  35 in total

1.  Unusual thrombotic cardiac complications of Pemphigus vulgaris: a new link?

Authors:  M Samir Arnaout; Adel Dimasi; Rami Harb; Samir Alam
Journal:  J Thromb Thrombolysis       Date:  2007-06       Impact factor: 2.300

2.  Daphnetin reduces endotoxin lethality in mice and decreases LPS-induced inflammation in Raw264.7 cells via suppressing JAK/STATs activation and ROS production.

Authors:  Lei Shen; Ting Zhou; Jing Wang; Xiumei Sang; Lei Lan; Lan Luo; Zhimin Yin
Journal:  Inflamm Res       Date:  2017-04-13       Impact factor: 4.575

3.  Antiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort.

Authors:  Darcy S Majka; Kiang Liu; Richard M Pope; Elizabeth W Karlson; Thanh-Huyen T Vu; Marius Teodorescu; Rowland W Chang
Journal:  Inflamm Res       Date:  2013-10       Impact factor: 4.575

4.  Nitric Oxide: Link between Inflammation and Endothelial Dysfunction in Rheumatoid Arthritis.

Authors:  Nidhi Garg; Ashit Syngle; Pawan Krishan
Journal:  Int J Angiol       Date:  2016-12-15

5.  Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status.

Authors:  Martha Savaria Morris; Lydia Sakakeeny; Paul F Jacques; Mary Frances Picciano; Jacob Selhub
Journal:  J Nutr       Date:  2009-11-11       Impact factor: 4.798

6.  Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies.

Authors:  Dharambir K Sanghera; Susan Manzi; Franklin Bontempo; Cara Nestlerode; M Ilyas Kamboh
Journal:  Hum Genet       Date:  2004-08-18       Impact factor: 4.132

7.  Arterial distensibility in chronic inflammatory rheumatic disorders.

Authors:  Mustafa Yildiz
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

8.  Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.

Authors:  G Vaudo; S Marchesi; R Gerli; R Allegrucci; A Giordano; D Siepi; M Pirro; Y Shoenfeld; G Schillaci; E Mannarino
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

9.  Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: a case report.

Authors:  Masato Kanazawa; Yoko Wada; Tsukasa Ohno; Hian In; Kazuaki Yahata; Junko Izumi; Hisao Tanaka; Satoshi Ito; Mitsuhiro Ueno; Masaaki Nakano; Fumitake Gejyo
Journal:  Clin Rheumatol       Date:  2004-04-14       Impact factor: 2.980

10.  Peripheral arterial disease in polymyalgia rheumatica.

Authors:  Frances A Borg; Bhaskar Dasgupta
Journal:  Arthritis Res Ther       Date:  2009-05-20       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.